In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Susanne Perkhofer1, Cornelia Mrazek, Lukas Hartl

  • 1Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Fritz Pregl Strasse 3, 6020, Innsbruck, Austria, susanne.perkhofer@i-med.ac.at.

Insights

In vitro antifungal susceptibility testing is crucial for managing invasive fungal infections in immunocompromised patients. However, correlating these tests with clinical outcomes remains challenging due to complex fungal biology.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Increasing prevalence of invasive fungal infections in immunocompromised patients undergoing transplantation, chemotherapy, or immunosuppression.
  • Emergence of antifungal resistance necessitates reliable susceptibility testing methods.
  • Growing population of immunocompromised hosts worldwide.

Purpose of the Study:

  • To review available in vitro antifungal susceptibility testing methods for yeasts and filamentous fungi.
  • To discuss the clinical implications and challenges of interpreting antifungal susceptibility test results.
  • To highlight the need for better correlation between in vitro data and in vivo outcomes.

Main Methods:

  • Review of established antifungal susceptibility testing procedures including macrodilution, microdilution, agar diffusion, disk diffusion, and Etest.
  • Analysis of existing data on clinical correlations of in vitro antifungal susceptibility testing.
  • Examination of the limitations of current susceptibility techniques in reflecting in vivo fungal biology.

Main Results:

  • Multiple in vitro methods exist for assessing antifungal susceptibility in fungi.
  • Clinical correlation of susceptibility testing remains a significant challenge.
  • Current in vitro methods do not fully capture the complex interactions between antifungals and fungi in vivo.

Conclusions:

  • In vitro antifungal susceptibility testing is essential for guiding treatment of invasive fungal infections.
  • Further research is needed to improve the clinical relevance of antifungal susceptibility testing.
  • Understanding the limitations of current methods is key to optimizing antifungal therapy in immunocompromised patients.

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...